Clinical Report: Recurrent Type III Pleuropulmonary Blastoma Case Study

Overview

This case study presents a 2-year-old boy diagnosed with recurrent type III pleuropulmonary blastoma (PPB) initially misidentified as embryonal rhabdomyosarcoma. The case underscores the importance of accurate tissue sampling and molecular testing in pediatric thoracic malignancies.

Background

Pleuropulmonary blastoma (PPB) is a rare and aggressive pediatric malignancy that can mimic other thoracic tumors, leading to diagnostic challenges. As the sentinel tumor for DICER1 syndrome, PPB carries significant implications for genetic counseling and surveillance for affected patients and their families. Understanding the clinical presentation and management of PPB is crucial for improving outcomes in pediatric oncology.

Data Highlights

No numerical or trial data available in the article.

Key Findings

• PPB can present with respiratory distress and pneumothorax, complicating diagnosis.
• Initial biopsy misinterpretation can lead to inappropriate treatment protocols.
• Pathogenic DICER1 mutations are associated with PPB, necessitating genetic counseling.
• Multimodal treatment, including surgical resection and chemotherapy, is essential for managing advanced PPB.
• Close follow-up is required due to the risk of severe cytopenias from chemotherapy.

Clinical Implications

Healthcare professionals should prioritize PPB in the differential diagnosis of pediatric thoracic masses. Adequate tissue sampling and expert pathology review are critical to avoid misdiagnosis and ensure appropriate management, including genetic counseling for DICER1 syndrome.

Conclusion

This case highlights the diagnostic complexities of PPB and the necessity for integrating molecular testing into clinical practice to guide treatment and surveillance strategies.

Related Resources & Content

1. DICER1-Related Tumor Predisposition - GeneReviews® - NCBI Bookshelf, 2026 -- Comprehensive guidelines for DICER1 testing.
2. Childhood Pleuropulmonary Blastoma Treatment (PDQ®) - PDQ Cancer Information Summaries, 2025 -- Overview of treatment protocols for PPB.
3. Pleuropulmonary Blastoma: A Report on 350 Central Pathology–Confirmed Pleuropulmonary Blastoma Cases by the International Pleuropulmonary Blastoma Registry, 2014 -- Analysis of PPB cases.
4. Acta Neuropathologica — Creation of Patient-Derived Models from a Metastatic Pediatric Diffuse Leptomeningeal Glioneuronal Tumor Featuring KIAA1549::BRAF Fusion
5. Journal of Neuro-Oncology — Reclassification of Central Nervous System Embryonal Tumors with EWSR1-PLAGL1 Rearrangements as INI-1 Deficient Tumors Upon Relapse
6. Acta Neuropathologica — PLAG1 Gene Fusions Broaden the Classification of CNS Tumors with PLAG(L) Alterations
7. Acta Neuropathologica — Uncommon IDH hotspot mutations in dysembryoplastic neuroepithelial tumors broaden the range of IDH-mutated central nervous system tumors
8. DICER1-Related Tumor Predisposition - GeneReviews® - NCBI Bookshelf
9. Childhood Pleuropulmonary Blastoma Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf
10. Pleuropulmonary Blastoma: A Report on 350 Central Pathology–Confirmed Pleuropulmonary Blastoma Cases by the International Pleuropulmonary Blastoma Registry - PMC